519 related articles for article (PubMed ID: 21263352)
1. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
2. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
3. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
4. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
5. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
[TBL] [Abstract][Full Text] [Related]
6. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
Nygård JF; Nygård M; Skare GB; Thoresen SO
Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
[TBL] [Abstract][Full Text] [Related]
7. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.
Uyar DS; Eltabbakh GH; Mount SL
Gynecol Oncol; 2003 May; 89(2):227-32. PubMed ID: 12713984
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening: who is not screened and why?
Harlan LC; Bernstein AB; Kessler LG
Am J Public Health; 1991 Jul; 81(7):885-90. PubMed ID: 2053665
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening among HIV-infected women in a health department setting.
Logan JL; Khambaty MQ; D'Souza KM; Menezes LJ
AIDS Patient Care STDS; 2010 Aug; 24(8):471-5. PubMed ID: 20653483
[TBL] [Abstract][Full Text] [Related]
11. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
12. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
13. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
[TBL] [Abstract][Full Text] [Related]
14. Metastatic melanoma of the uterine cervix diagnosed on cervical Pap smear: Case report and literature review.
Shachner TR; Van Meter SE
Diagn Cytopathol; 2018 Dec; 46(12):1045-1049. PubMed ID: 30354020
[TBL] [Abstract][Full Text] [Related]
15. [Following-up females having an abnormal Pap smear in Colombia].
Wiesner C; Cendales R; Murillo R; Piñeros M; Tovar S
Rev Salud Publica (Bogota); 2010 Feb; 12(1):1-13. PubMed ID: 20628695
[TBL] [Abstract][Full Text] [Related]
16. [Previous screening for cervical cancer among women with cytological and histological abnormalities].
Rama C; Roteli-Martins C; Derchain S; Longatto-Filho A; Gontijo R; Sarian L; Syrjanen K; Ching T; Aldrighi J
Rev Saude Publica; 2008 Jun; 42(3):411-9. PubMed ID: 18470363
[TBL] [Abstract][Full Text] [Related]
17. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
Strander B; Andersson-Ellström A; Milsom I; Rådberg T; Ryd W
Cancer; 2007 Oct; 111(5):285-91. PubMed ID: 17724676
[TBL] [Abstract][Full Text] [Related]
18. Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.
Khumthong K; Aue-Aungkul A; Kleebkaow P; Chumworathayi B; Temtanakitpaisan A; Nhokaew W
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2847-2850. PubMed ID: 31554386
[TBL] [Abstract][Full Text] [Related]
19. Screening History in 313 Cases of Invasive Cancer: A Retrospective Review of Cervical Cancer Screening in Alberta, Canada.
Mema SC; Nation J; Yang H; Waghray R; Sun MC; Xu L; Kliewer G
J Low Genit Tract Dis; 2017 Jan; 21(1):17-20. PubMed ID: 27824788
[TBL] [Abstract][Full Text] [Related]
20. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
Nygård JF; Nygård M; Skare GB; Thoresen SØ
Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]